| Trial ID: | L0743 |
| Source ID: | IRCT20180903040941N1
|
| Associated Drug: |
Matricaria
|
| Title: |
The effect of Matricaria chamomilla L. on insulin resistance, inflammatory status and other related indices in patients with non-alcoholic fatty liver
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non alcoholic fatty liver. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group: A capsule containing 500 mg of chamomile flower powder will be taken four times a day, two fasting morning and two nights before bedtime for three months. Intervention 2: Control group: placebo capsules containing roast
|
| Outcome Measures: |
Fatty liver grade. Timepoint: Initially and three months later. Method of measurement: Ultrasound.;Hepatic aminotransferases. Timepoint: Initially and six weeks later and three months later. Method of measurement: Laboratory Kit.;Fatty liver index(FLI). Timepoint: Initially and three months later. Method of measurement: Using formula: [e 0.953*loge (triglycerides) + 0.139*BMI + 0.718*loge (ggt) + 0.053*waist circumference - 15.745) / (1 + e 0.953*loge (triglycerides) + 0.139*BMI + 0.718*loge (ggt) + 0.053*waist circumference - 15.745)] ?? 100.;Alpha Tumor Necrosis Factor. Timepoint: Initially and three months later. Method of measurement: Laboratory Kit.;Insulin resistance index. Timepoint: Initially and three months later. Method of measurement: Calculate the HOMA-IR.;Alkaline phosphatase. Timepoint: initially and three months later. Method of measurement: Laboratory Kit.Body mass composition. Timepoint: At the entrance and three months later. Method of measurement: Body mass composition machine.;Inflammation. Timepoint: At the entrance and three months later. Method of measurement: hs-CRP labratory kit.;Lipide profile. Timepoint: At the entrance and three months later. Method of measurement: Blood test.
|
| Sponsor/Collaborators: |
Fasa University of Medical Sciences
|
| Gender: |
All
|
| Age: |
25 years65 years
|
| Phases: |
Not applicable
|
| Enrollment: |
44
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization method: Simple randomization Random unit: Individual Randomization Tool: Random Numbers, Blinding descri
|
| Start Date: |
03/06/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
26 August 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/33681
|
